Cargando…
The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease
PURPOSE: Indoxyl sulfate (IS) is one of the most potent uremic toxins involved in chronic kidney disease (CKD) progression, induction of inflammation, oxidative stress, and cardiovascular diseases occurrence. It is proved that hypertension is a common CVD complication and a major death risk factor a...
Autores principales: | Kaminski, Tomasz W., Pawlak, Krystyna, Karbowska, Malgorzata, Znorko, Beata, Mor, Adrian L., Mysliwiec, Michal, Pawlak, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424951/ https://www.ncbi.nlm.nih.gov/pubmed/30617956 http://dx.doi.org/10.1007/s11255-018-02064-3 |
Ejemplares similares
-
Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
por: Kamiński, Tomasz W., et al.
Publicado: (2017) -
Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2017) -
Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020) -
The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models
por: Karbowska, Malgorzata, et al.
Publicado: (2017) -
Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3
por: Karbowska, Malgorzata, et al.
Publicado: (2018)